Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma

The proteoglycan versican (VCAN) promotes tumor progression and enhances metastasis in several cancers; however, its role in clear cell renal cell carcinoma (ccRCC) remains unknown. Recent evidence suggests that VCAN is an important target of chromosomal 5q gain, one of the most prevalent genetic ab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Res
Main Authors: Mitsui, Yozo, Shiina, Hiroaki, Kato, Taku, Maekawa, Shigekatsu, Hashimoto, Yutaka, Shiina, Marisa, Imai-Sumida, Mitsuho, Kulkarni, Priyanka, Dasgupta, Pritha, Wong, Ryan Kenji, Hiraki, Miho, Arichi, Naoko, Fukuhara, Shinichiro, Yamamura, Soichiro, Majid, Shahana, Saini, Sharanjot, Deng, Guoren, Dahiya, Rajvir, Nakajima, Koichi, Tanaka, Yuichiro
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890926/
https://ncbi.nlm.nih.gov/pubmed/28242813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-16-0444
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares